Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 488

1.

Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study.

Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA.

Diabetes Care. 2007 Jan;30(1):128-34.

PMID:
17192345
2.

Cost effectiveness of community-based physical activity interventions.

Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE, Heath G, Kohl HW 3rd, Teutsch S, Cawley J, Lee IM, West L, Buchner DM.

Am J Prev Med. 2008 Dec;35(6):578-88. doi: 10.1016/j.amepre.2008.06.040.

PMID:
19000846
3.

An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes.

Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, Zhang P, Engelgau MM, Ratner RE, Herman WH.

Diabetes Care. 2006 Jun;29(6):1237-41.

PMID:
16732002
4.

Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN).

Wolf AM, Siadaty M, Yaeger B, Conaway MR, Crowther JQ, Nadler JL, Bovbjerg VE.

J Am Diet Assoc. 2007 Aug;107(8):1365-73.

PMID:
17659904
5.

Cost-effectiveness of lifestyle modification in diabetic patients.

Jacobs-van der Bruggen MA, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, Feskens EJ, Baan CA.

Diabetes Care. 2009 Aug;32(8):1453-8. doi: 10.2337/dc09-0363. Epub 2009 May 12.

6.

The Healthy Lifestyle Change Program: a pilot of a community-based health promotion intervention for adults with developmental disabilities.

Bazzano AT, Zeldin AS, Diab IR, Garro NM, Allevato NA, Lehrer D; WRC Project Oversight Team.

Am J Prev Med. 2009 Dec;37(6 Suppl 1):S201-8. doi: 10.1016/j.amepre.2009.08.005.

PMID:
19896020
7.

Cost-effectiveness of diabetes self-management programs in community primary care settings.

Brownson CA, Hoerger TJ, Fisher EB, Kilpatrick KE.

Diabetes Educ. 2009 Sep-Oct;35(5):761-9. doi: 10.1177/0145721709340931. Epub 2009 Jul 21.

PMID:
19622716
8.

The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.

Bemelmans W, van Baal P, Wendel-Vos W, Schuit J, Feskens E, Ament A, Hoogenveen R.

Prev Med. 2008 Feb;46(2):127-32. Epub 2007 Aug 3.

PMID:
17822752
9.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

10.

Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.

Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, Ackermann RT, Zhang P, Engelgau MM.

Diabetes Care. 2007 Nov;30(11):2874-9. Epub 2007 Aug 13.

PMID:
17698614
11.

Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.

Bertram MY, Lim SS, Barendregt JJ, Vos T.

Diabetologia. 2010 May;53(5):875-81. doi: 10.1007/s00125-010-1661-8. Epub 2010 Feb 5.

PMID:
20135088
12.

Clinical and cost-effectiveness of primary prevention of Type 2 diabetes in a 'real world' routine healthcare setting: model based on the KORA Survey 2000.

Icks A, Rathmann W, Haastert B, Gandjour A, Holle R, John J, Giani G; KORA Study Group.

Diabet Med. 2007 May;24(5):473-80. Epub 2007 Mar 22.

PMID:
17381502
13.

The European perspective of type 2 diabetes prevention: diabetes in Europe--prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.

Schwarz PE, Lindström J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J; DE-PLAN project.

Exp Clin Endocrinol Diabetes. 2008 Mar;116(3):167-72. doi: 10.1055/s-2007-992115.

PMID:
18350480
14.
15.

Lifestyle intervention to prevent diabetes: intensive and cost effective.

Wylie-Rosett J, Herman WH, Goldberg RB.

Curr Opin Lipidol. 2006 Feb;17(1):37-44.

PMID:
16407714
16.

Cost-effectiveness of interventions promoting physical activity.

Müller-Riemenschneider F, Reinhold T, Willich SN.

Br J Sports Med. 2009 Jan;43(1):70-6. doi: 10.1136/bjsm.2008.053728. Epub 2008 Oct 29. Review.

PMID:
18971249
17.

Cost-effectiveness of sitagliptin-based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy.

Schwarz B, Gouveia M, Chen J, Nocea G, Jameson K, Cook J, Krishnarajah G, Alemao E, Yin D, Sintonen H.

Diabetes Obes Metab. 2008 Jun;10 Suppl 1:43-55. doi: 10.1111/j.1463-1326.2008.00886.x.

PMID:
18435673
19.

Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.

Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I.

Health Technol Assess. 2007 Oct;11(42):1-294.

20.

Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).

Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z.

Diabetes Care. 2007 Oct;30(10):2548-52. Epub 2007 Aug 1.

PMID:
17670917
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk